Cited by 1,509Acute Myocardial Infarction ResearchCardiac Health and Mental HealthCardiac Ischemia and Reperfusion

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

beta Blockade after myocardial infarction: systematic review and meta regression analysis

Open access

Freemantle, N., Cleland, J., Young, P., Mason, J., Harrison, J.·1999·BMJ

DOI 10.1136/bmj.318.7200.1730PMC PMC31101

Open this paper in CoChat — free account Open PDF

Abstract

OBJECTIVES: To assess the effectiveness of beta blockers in short term treatment for acute myocardial infarction and in longer term secondary prevention; to examine predictive factors that may influence outcome and therefore choice of drug; and to examine the clinical importance of the results in the light of current treatment. DESIGN: Systematic review of randomised controlled trials. SETTING: Randomised controlled trials. SUBJECTS: Patients with acute or past myocardial infarction. INTERVENTION: beta Blockers compared with control. MAIN OUTCOME MEASURES: All cause mortality and non-fatal reinfarction. RESULTS: Overall, 5477 of 54 234 patients (10.1%) randomised to beta blockers or control died. We identified a 23% reduction in the odds of death in long term trials (95% confidence interval 15% to 31%), but only a 4% reduction in the odds of death in short term trials (-8% to 15%). Meta regression in long term trials did not identify a significant reduction in effectiveness in drugs with cardioselectivity but did identify a near significant trend towards decreased benefit in drugs with intrinsic sympathomimetic activity. Most evidence is available for propranolol, timolol, and metoprolol. In long term trials, the number needed to treat for 2 years to avoid a death is 42, which compares favourably with other treatments for patients with acute or past myocardial infarction. CONCLUSIONS: beta Blockers are effective in long term secondary prevention after myocardial infarction, but they are underused in such cases and lead to avoidable mortality and morbidity.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1136/bmj.318.7200.1730

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Untitled work
Schulz (1995) · doi:10.1001/jama.1995.03520290060030 · Cited by 5,634
COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS
Altman, R., Carreras, L., Díaz, R. S., Figueroa, E. B., Paolasso, E., Parodi, J. C., Cade, J. F., Donnan, G. A., Eadie, M. J., Gavaghan, T. P., et al. (1994) · Cited by 3,322
Beta blockade during and after myocardial infarction: An overview of the randomized trials
Yusuf, S., Peto, R., Lewis, J., Collins, R., & Sleight, P. (1985) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(85)80003-7 · Cited by 3,205
Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.
Sleight, R. B., Sleight, P., Parish, S., Appleby, P. N., Collins, R., & Baigent, C. (1988) · PubMed · Cited by 2,868
Comparison of Invasive and Conservative Strategies after Treatment with Intravenous Tissue Plasminogen Activator in Acute Myocardial Infarction
The TIMI Study Group* (1989) · New England Journal of Medicine · doi:10.1056/nejm198903093201002 · Cited by 1,024
Effect of Beta-Blockade on Mortality among High-Risk and Low-Risk Patients after Myocardial Infarction
Gottlieb, S. S., McCarter, R., & Vogel, R. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808203390801 · Cited by 966
The Effect of Diltiazem on Mortality and Reinfarction after Myocardial Infarction
The Multicenter Diltiazem Postinfarction Trial Research Group (1988) · New England Journal of Medicine · doi:10.1056/nejm198808183190701 · Cited by 828
Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.
(1994) · Europe PMC (PubMed Central) · Cited by 755
The Effect of Warfarin on Mortality and Reinfarction after Myocardial Infarction
Smith, P., Arnesen, H., & Holme, I. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007193230302 · Cited by 637

Show all 34 references

Research works printed but not linked: 3

Viskin S, Barron HV. -Blockers prevent cardiac death following myocar- dial infarction: so why are so many infarct survivors discharge without -blockers? Am J Cardiol 1996;78:821-2.
Spiegelhalter D, Thomas A, Best N, Gilks W. BUGS: Bayesian inference using Gibbs sampling, Version 0.50. Cambridge: Medical Research Council Biostatistics Unit, 1995.
Feely J, de Vane PJ, Maclean D. -Blockers and sympathomimetics. BMJ 1983;286:1043-7.

Sorted by citations

Items 101–200 of 1,000

MANAGEMENT OF ACUTE MYOCARDIAL INFARCTION IN PATIENTS PRESENTING WITH ST-SEGMENT ELEVATION
de Werf, F. V., Ardissino, D., Betriu, A., Cokkinos, D., Falk, E., Fox, K. A. A., Julian, D. G., Lengyel, M., Neumann, F., Ruzyllo, W., et al. (2005) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2005-1-2-62-95 · Cited by 322
Acute myocardial infarction
Boersma, E. H., Mercado, N. F., Poldermans, D., Gardien, M., Vos, J., & Simoons, M. L. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12712-2 · Cited by 327
2023 ESC Guidelines for the management of acute coronary syndromes
Byrne, R. A., Rosselló, X., Coughlan, J. J., Barbato, E., Berry, C., Chieffo, A., Claeys, M. J., Dan, G., Dweck, M. R., Galbraith, M., et al. (2023) · European Heart Journal Acute Cardiovascular Care · doi:10.1093/ehjacc/zuad107 · Cited by 373
National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Management of Acute Coronary Syndromes 2016
Chew, D. P., Scott, I. A., Cullen, L., French, J. K., Briffa, T. G., Tideman, P. A., Woodruffe, S., Kerr, A., Branagan, M., & Aylward, P. E. (2016) · Heart Lung and Circulation · doi:10.1016/j.hlc.2016.06.789 · Cited by 326
The health impact of health care on families: a matched cohort study of hospice use by decedents and mortality outcomes in surviving, widowed spouses.
Christakis, N., & Iwashyna, T. (2003) · Social Science & Medicine (1967) · doi:10.1016/s0277-9536(02)00370-2 · Cited by 340
European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012)
Perk, J., Backer, G. D., Gohlke, H., Graham, I. M., Reiner, Ž., Verschuren, W. M. M., Albus, C., Benlian, P., Boysen, G., Cífková, R., et al. (2012) · International Journal of Behavioral Medicine · doi:10.1007/s12529-012-9242-5 · Cited by 319
The Association Between Emergency Department Crowding and Adverse Cardiovascular Outcomes in Patients with Chest Pain
Pines, J. M., Pollack, C. V., Diercks, D. B., Chang, A. M., Shofer, F. S., & Hollander, J. E. (2009) · Academic Emergency Medicine · doi:10.1111/j.1553-2712.2009.00456.x · Cited by 289
WHO study on Prevention of REcurrences of Myocardial Infarction and StrokE (WHO-PREMISE).
Mendis, S., Abegunde, D., Yusuf, S., Ebrahim, S. B. J., Shaper, G., Ghannem, H., & Shengelia, B. (2005) · Europe PMC (PubMed Central) · Cited by 286
Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts)
Graham, I. D., Atar, D., Borch‐Johnsen, K., Boysen, G., Burell, G. K., Cífková, R., Dallongeville, J., Backer, G. D., Ebrahim, S. B. J., Gjelsvik, B., et al. (2007) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000277984.31558.c4 · Cited by 299
2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
Anderson, J. L., Adams, C. D., Antman, E. M., Bridges, C. R., Califf, R. M., Casey, D. E., Chavey, W. E., Fesmire, F. M., Hochman, J. S., Levin, T. N., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31828478ac · Cited by 275
Mitochondria as a Drug Target in Ischemic Heart Disease and Cardiomyopathy
Walters, A. M., Porter, G. A., & Brookes, P. S. (2012) · Circulation Research · doi:10.1161/circresaha.112.265660 · Cited by 272
Effect Size Estimates of Lifestyle and Dietary Changes on All-Cause Mortality in Coronary Artery Disease Patients
Iestra, J. A., Kromhout, D., van der Schouw, Y. T., Grobbee, D. E., Boshuizen, H. C., & van Staveren, W. A. (2005) · Circulation · doi:10.1161/circulationaha.104.503995 · Cited by 265
Cardioselective β-Blockers in Patients with Reactive Airway Disease
Salpeter, S. R., Ormiston, T. M., & Salpeter, E. E. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-9-200211050-00035 · Cited by 262
THE ASSOCIATION BETWEEN ANXIETY DISORDERS AND SUICIDAL BEHAVIORS: A SYSTEMATIC REVIEW AND META-ANALYSIS
Kanwar, A., Malik, S., Prokop, L. J., Sim, L. A., Feldstein, D., Wang, Z., & Murad, M. H. (2013) · Depression and Anxiety · doi:10.1002/da.22074 · Cited by 282
Uses and abuses of meta-analysis
Egger, M., Smith, G. D., & Sterne, J. A. C. (2001) · Clinical Medicine · doi:10.7861/clinmedicine.1-6-478 · Cited by 258
Principles of and Procedures for Systematic Reviews
Egger, M., & Smith, G. D. (2001) · Wiley eBooks · doi:10.1002/9780470693926.ch2 · Cited by 255
Reperfusion Injury in Patients With Acute Myocardial Infarction
Welt, F. G. P., Batchelor, W., Spears, J. R., Penna, C. R. R., Pagliaro, P., Ibáñez, B., Drakos, S. G., Dangas, G., & Kapur, N. K. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.02.056 · Cited by 263
Part 10: Acute Coronary Syndromes
O’Connor, R. E., Brady, W. J., Brooks, S. C., Diercks, D., Egan, J. R., Ghaemmaghami, C. A., Menon, V., O’Neil, B. J., Travers, A. H., & Yannopoulos, D. (2010) · Circulation · doi:10.1161/circulationaha.110.971028 · Cited by 255
Meta-regression detected associations between heterogeneous treatment effects and study-level, but not patient-level, factors
Schmid, C. H., Stark, P. C., Berlin, J. A., Landais, P., & Lau, J. (2004) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2003.12.001 · Cited by 245
2020 Clinical practice guidelines for Acute ST-segment elevation myocardial infarction
Russian Society of Cardiology (2020) · Russian Journal of Cardiology · doi:10.15829/29/1560-4071-2020-4103 · Cited by 271
Global Perspective on Acute Coronary Syndrome
Vedanthan, R., Seligman, B. J., & Fuster, V. (2014) · Circulation Research · doi:10.1161/circresaha.114.302782 · Cited by 253
Propranolol for the treatment of anxiety disorders: Systematic review and meta-analysis
Steenen, S. A., van Wijk, A. J., van der Heijden, G. J., van Westrhenen, R., de Lange, J., & de Jongh, A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881115612236 · Cited by 237
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease: Executive Summary
Fihn, S. D., Gardin, J. M., Abrams, J., Berra, K., Blankenship, J. C., Dallas, A. P., Douglas, P. S., Foody, J. M., Gerber, T. C., Hinderliter, A. L., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.07.012 · Cited by 242
β-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular Dysfunction
Dondo, T. B., Hall, M., West, R. M., Jernberg, T., Lindahl, B., Bueno, H., Danchin, N., Deanfield, J. E., Hemingway, H., Fox, K. A. A., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.03.578 · Cited by 237
Cardiovascular Protection Using Beta-Blockers
Bangalore, S., Messerli, F. H., Kostis, J. B., & Pepine, C. J. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.04.060 · Cited by 233
2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery: Executive Summary
Fleisher, L. A., Fleischmann, K. E., Auerbach, A. D., Barnason, S. A., Beckman, J. A., Bozkurt, B., Dávila‐Román, V. G., Gerhard‐Herman, M. D., Holly, T. A., Kane, G. C., et al. (2014) · Journal of Nuclear Cardiology · doi:10.1007/s12350-014-0025-z · Cited by 235
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)
Authors/Task Force Members: Joep Perk (Chairperson) (Sweden)*, G. D. B. (. (2012) · European Journal of Preventive Cardiology · doi:10.1177/2047487312450228 · Cited by 863
Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial
Fox, K. M., Ford, I., Steg, P. G., Tendera, M., Robertson, M., Ferrari, R., & on behalf of the BEAUTIFUL Investigators (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp358 · Cited by 223
The use of the propensity score for estimating treatment effects: administrative versus clinical data
Austin, P. C., Mamdani, M., Stukel, T. A., Anderson, G. M., & Tu, J. V. (2005) · Statistics in Medicine · doi:10.1002/sim.2053 · Cited by 222
A wearable haemodialysis device for patients with end-stage renal failure: a pilot study
Davenport, A., Gura, V., Ronco, C., Beizai, M., Ezon, C., & Rambod, E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61864-9 · Cited by 218
ACC/AHA 2008 Performance Measures for Adults With ST-Elevation and Non–ST-Elevation Myocardial Infarction
Krumholz, H. M., Anderson, J. L., Bachelder, B. L., Fesmire, F. M., Fihn, S. D., Foody, J. M., Ho, P. M., Kosiborod, M., Masoudi, F. A., & Nallamothu, B. K. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.10.012 · Cited by 218
A Meta-Analysis of 17 Randomized Trials of a Percutaneous Coronary Intervention-Based Strategy in Patients With Stable Coronary Artery Disease
Schömig, A., Mehilli, J., de Waha, A., Seyfarth, M., Pache, J., & Kastrati, A. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.05.051 · Cited by 211
Intracellular cAMP Sensor EPAC: Physiology, Pathophysiology, and Therapeutics Development
Robichaux, W. G., & Cheng, X. (2018) · Physiological Reviews · doi:10.1152/physrev.00025.2017 · Cited by 222
Perioperative myocardial infarction—aetiology and prevention
Priebe, H. (2005) · British Journal of Anaesthesia · doi:10.1093/bja/aei063 · Cited by 201
Comparative effectiveness of exercise and drug interventions on mortality outcomes: metaepidemiological study
Naci, H., & Ioannidis, J. P. A. (2015) · British Journal of Sports Medicine · doi:10.1136/bjsports-2015-f5577rep · Cited by 215
Recent advances in the diagnosis and treatment of acute myocardial infarction
Reddy, K. R. (2015) · World Journal of Cardiology · doi:10.4330/wjc.v7.i5.243 · Cited by 199
Long-Term Benefit of Early Pre-Reperfusion Metoprolol Administration in Patients With Acute Myocardial Infarction
Pizarro, G., Fernández‐Friera, L., Fuster, V., Fernández‐Jiménez, R., García-Ruiz, J. M., García‐Álvarez, A., Rodríguez, A. A. M., Barreiro, M. V., Escalera, N., Rodriguez, M. D., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.014 · Cited by 197
β blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study
Puymirat, É., Riant, E., Aissoui, N., Soria, A., Ducrocq, G., Coste, P., Cottin, Y., Aupetit, J. F., Bonnefoy‐Cudraz, E., Blanchard, D., et al. (2016) · BMJ · doi:10.1136/bmj.i4801 · Cited by 189
2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non–ST-Elevation Myocardial Infarction
Jneid, H. M., Addison, D., Bhatt, D. L., Fonarow, G. C., Gokak, S. Z., Grady, K. L., Green, L. A., Heidenreich, P. A., Ho, P. M., Jurgens, C. Y., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.06.032 · Cited by 194
“The effects of beta blockers appear also to be greatest among patients with MI complicated by heart failure, systolic cardiomyopathy, or ventricular arrhythmias.(48) Although not prospectively studied, the AHA/ACCF secondary prevention guidelines recommend a 3-year treatment course with beta blockers for patients with…”
BackgroundInfluential
Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms and Strategies for Cardioprotection
Morelli, M. B., Bongiovanni, C., Pra, S. D., Miano, C., Sacchi, F., Lauriola, M., & D’Uva, G. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.847012 · Cited by 195
Left Ventricular Remodeling After Anterior Wall Acute Myocardial Infarction in Modern Clinical Practice (from the REmodelage VEntriculaire [REVE] Study Group)
Savoye, C., Equine, O., Tricot, O., Nugue, O., Segrestin, B., Sautière, K., Elkohen, M., Pretorian, E.-M., Taghipour, K., Philias, A., et al. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.06.011 · Cited by 189
Effects of Beta-Adrenergic Antagonists in Patients With Chronic Kidney Disease
Badve, S. V., Roberts, M. A., Hawley, C. M., Cass, A., Garg, A. X., Krum, H., Tonkin, A. M., & Perkovic, V. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.04.041 · Cited by 177
Long-term Medication Adherence after Myocardial Infarction: Experience of a Community
Shah, N. D., Dunlay, S. M., Ting, H. H., Montori, V. M., Thomas, R. J., Wagie, A. E., & Roger, V. L. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.12.021 · Cited by 179
A systematic review and meta-analysis of tests to predict wound healing in diabetic foot.
Wang, Z., Hasan, R., Firwana, B., Elraiyah, T., Tsapas, A., Prokop, L., Mills, J. L., & Murad, M. H. (2016) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2015.10.004 · Cited by 173
Quantitative relationship between resting heart rate reduction and magnitude of clinical benefits in post-myocardial infarction: a meta-regression of randomized clinical trials
Cucherat, M. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm489 · Cited by 182
Antihypertensive Therapy and Incidence of Type 2 Diabetes
Padwal, R. S., & Laupacis, A. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.247 · Cited by 173
National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the management of acute coronary syndromes 2016
Chew, D. P., Scott, I. A., Cullen, L., French, J. K., Briffa, T. G., Tideman, P. A., Woodruffe, S., Kerr, A., Branagan, M., & Aylward, P. E. (2016) · The Medical Journal of Australia · doi:10.5694/mja16.00368 · Cited by 171
Leitlinien zur Therapie der chronischen Herzinsuffizienz
Hoppe, U. C., Böhm, M., Dietz, R., Hanrath, P., Kroemer, H. K., Osterspey, A., SCHMALTZ, A. A., & Erdmann, E. (2005) · Zeitschrift für Kardiologie · doi:10.1007/s00392-005-0268-4 · Cited by 181
2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non–ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures
Jneid, H. M., Addison, D., Bhatt, D. L., Fonarow, G. C., Gokak, S. Z., Grady, K. L., Green, L. A., Heidenreich, P. A., Ho, P. M., Jurgens, C. Y., et al. (2017) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/hcq.0000000000000032 · Cited by 172
ACC/AHA 2008 Performance Measures for Adults With ST-Elevation and Non–ST-Elevation Myocardial Infarction
Krumholz, H. M., Anderson, J. L., Bachelder, B. L., Fesmire, F. M., Fihn, S. D., Foody, J. M., Ho, P. M., Kosiborod, M., Masoudi, F. A., & Nallamothu, B. K. (2008) · Circulation · doi:10.1161/circulationaha.108.191099 · Cited by 170
Long-Term Use of Cardiovascular Drugs
Rosselló, X., Pocock, S., & Julian, D. G. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.07.018 · Cited by 171
Improved Survival of Diabetic Foot Ulcer Patients 1995–2008
Young, M. J., McCardle, J., Randall, L. E., & Barclay, J. (2008) · Diabetes Care · doi:10.2337/dc08-1242 · Cited by 165
Leitlinien: Akutes Koronarsyndrom (ACS)
Hamm, C. W. (2004) · Zeitschrift für Kardiologie · doi:10.1007/s00392-004-0109-x · Cited by 163
Adverse Effects of β-Blocker Therapy for Patients With Heart Failure
Ko, D. T., Hebert, P. R., Coffey, C. S., Curtis, J. P., Foody, J. M., Sedrakyan, A., & Krumholz, H. M. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.13.1389 · Cited by 161
Angiotensin-Converting Enzyme Inhibitors in Patients With Coronary Artery Disease and Absence of Heart Failure or Left Ventricular Systolic Dysfunction
Danchin, N., Cucherat, M., Thuillez, C., Durand, É., Kadri, Z., & Steg, P. G. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.7.787 · Cited by 159
Cardiovascular disease and anaphylaxis
Mueller, U. R. (2007) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0b013e328259c328 · Cited by 151
Excess recurrent cardiac events in rheumatoid arthritis patients with acute coronary syndrome
Douglas, K., Pace, A. V., Treharne, G. J., Saratzis, A. N., Nightingale, P., Erb, N., Banks, M. J., & Kitas, G. D. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.037978 · Cited by 146
Cardioselective beta-blockers for chronic obstructive pulmonary disease: a meta-analysis
Salpeter, S. R., Ormiston, T. M., Salpeter, E. E., Poole, P., & Cates, C. J. (2003) · Respiratory Medicine · doi:10.1016/s0954-6111(03)00168-9 · Cited by 144
Does beta-blocker therapy improve clinical outcomes of acute myocardial infarction after successful primary angioplasty?
Kernis, S. J., Harjai, K. J., Stone, G. W., Grines, L. L., Boura, J., O’Neill, W. W., & Grines, C. L. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.09.071 · Cited by 145
Effect of Beta-Blocker Dose on Survival After Acute Myocardial Infarction
Goldberger, J. J., Bonow, R. O., Cuffe, M. S., Liu, L., Rosenberg, Y., Shah, P. K., Smith, S. C., & Subacius, H. P. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.07.047 · Cited by 144
Outcomes After Acute Myocardial Infarction in HIV-Infected Patients
Lorgis, L., Cottenet, J., Molins, G., Benzenine, É., Zeller, M., Aube, H., Touzery, C., Hamblin, J., Gudjoncik, A., Cottin, Y., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.001874 · Cited by 151
The rationale and emergence of electroconductive biomaterial scaffolds in cardiac tissue engineering
Solazzo, M., O’Brien, F. J., Nicolosi, V., & Monaghan, M. G. (2019) · APL Bioengineering · doi:10.1063/1.5116579 · Cited by 150
Heart Failure and Chronic Obstructive Pulmonary Disease
Hawkins, N. M., Petrie, M. C., MacDonald, M. R., Jhund, P. S., Fabbri, L. M., Wikstrand, J., & McMurray, J. J. V. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.02.020 · Cited by 144
Intensive statin therapy in acute coronary syndromes and stable coronary heart disease: a comparative meta-analysis of randomised controlled trials
Afilalo, J., Majdan, A. A., & Eisenberg, M. J. (2007) · Heart · doi:10.1136/hrt.2006.112508 · Cited by 143
Depression, heart rate related variables and cardiovascular disease
Taylor, C. B. (2010) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2010.04.006 · Cited by 147
“…of 82 randomized trials (31 with long-term follow-up) provided strong evidence for the long-term use of beta-blockers to reduce morbidity and mortality after acute MI even if aspirin, fibrinolytics, or angiotensin converting enzyme inhibitors were coadministered (Freemantle et al., 1999).”
Background
Cardiovascular drug class specificity: β-blockers
Reiter, M. J. (2004) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2004.04.004 · Cited by 143
Use of β-blockers during immunotherapy for Hymenoptera venom allergy
Müller, U., & Haeberli, G. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.11.012 · Cited by 120
Functionalized nanoparticles provide early cardioprotection after acute myocardial infarction
Chang, M., Yang, Y.-J., Chang, C.-H., Tang, A. C. L., Liao, W.-Y., Cheng, F., Yeh, C., Lai, J. J., Stayton, P. S., & Hsieh, P. C. H. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.04.022 · Cited by 148
2020 Clinical practice guidelines for Acute coronary syndrome without ST segment elevation
Барбараш, О. Л., Duplyakov, D. V., Zateischikov, D. A., Панченко, Е. П., Shakhnovich, R. M., Yavelov, I. S., Yakovlev, A. N., Sa, A., Alekyan, B. G., Викторович, А. М., et al. (2021) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2021-4449 · Cited by 147
Smoking Status and Long-Term Survival After First Acute Myocardial Infarction
Gerber, Y., Rosen, L., Goldbourt, U., Benyamini, Y., & Drory, Y. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.09.020 · Cited by 132
Beta-Blocker Therapy and Cardiac Events Among Patients With Newly Diagnosed Coronary Heart Disease
Andersson, C., Shilane, D. A., Go, A. S., Chang, T. I., Kazi, D. S., Solomon, M. D., Boothroyd, D. B., & Hlatky, M. A. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.04.042 · Cited by 132
Effect of Electronic Reminders, Financial Incentives, and Social Support on Outcomes After Myocardial Infarction
Volpp, K. G. M., Troxel, A. B., Mehta, S. J., Norton, L. A., Zhu, J., Lim, R., Wang, W., Marcus, N., Terwiesch, C., Caldarella, K. L., et al. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.2449 · Cited by 130
Ethnicity and cardiovascular disease prevention in the United Kingdom: a practical approach to management
Lip, G. Y. H., Barnett, A. H., Bradbury, A. W., Cappuccio, F. P., Gill, P. S., Hughes, E. A., Imray, C., Jolly, K. B., & Patel, K. (2007) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1002126 · Cited by 132
Under-use of beta-blockers in patients with ischaemic heart disease and concomitant chronic obstructive pulmonary disease
Egred, M., Shaw, S. M., Mohammad, B., Waitt, P. I., & Rodrigues, E. (2005) · QJM · doi:10.1093/qjmed/hci080 · Cited by 129
Reporting of adverse drug reactions in randomised controlled trials – a systematic survey
Loke, Y. K., & Derry, S. (2001) · BMC Clinical Pharmacology · doi:10.1186/1472-6904-1-3 · Cited by 128
Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction
Ibáñez, B., Latini, R., Rosselló, X., Domínguez‐Rodríguez, A., Fernández‐Vázquez, F., Pelizzoni, V., Sánchez, P. L., Anguita, M. P., Barrabés, J. A., Raposeiras‐Roubín, S., et al. (2025) · New England Journal of Medicine · doi:10.1056/nejmoa2504735 · Cited by 138
Measuring and Improving Quality in Emergency Medicine
Graff, L., Stevens, C. M., Spaite, D. W., & Foody, J. (2002) · Academic Emergency Medicine · doi:10.1111/j.1553-2712.2002.tb01563.x · Cited by 125
Antihypertensives for Kidney Transplant Recipients: Systematic Review and Meta-Analysis of Randomized Controlled Trials
Cross, N., Webster, A. C., Masson, P., O’Connell, P. J., & Craig, J. C. (2009) · Transplantation · doi:10.1097/tp.0b013e3181a9e960 · Cited by 126
Using medications appropriately in older adults.
Willlams, C. M. (2002) · PubMed · Cited by 124
Análisis de la disminución de la mortalidad por enfermedad coronaria en una población mediterránea: España 1988-2005
Flores‐Mateo, G., Grau, M., O’Flaherty, M., Ramos, R., Elosúa, R., Violán, C., Quesada, M., Martí‐Lluch, R., Sala, J., Marrugat, J., et al. (2011) · Revista Española de Cardiología · doi:10.1016/j.recesp.2011.05.033 · Cited by 127
Part 9: Acute Coronary Syndromes
O’Connor, R. E., Ali, A. S., Brady, W. J., Ghaemmaghami, C. A., Menon, V., Welsford, M., & Shuster, M. (2015) · Circulation · doi:10.1161/cir.0000000000000263 · Cited by 128
World Heart Federation Roadmap for Secondary Prevention of Cardiovascular Disease: 2023 Update
Laranjo, L., Lanas, F. T., Sun, M. C., Chen, D. A., Hynes, L., Imran, T. F., Kazi, D. S., Kengne, A. P., Komiyama, M., Kuwabara, M., et al. (2024) · Global Heart · doi:10.5334/gh.1278 · Cited by 143
“They are particularly important to be continued in patients with reduced left ventricular function [76, 77].”
Background
The Role of the New β-Blockers in Treating Cardiovascular Disease
Weber, M. A. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2005.09.009 · Cited by 120
Part 9: Acute Coronary Syndromes
O’Connor, R. E., Bossaert, L. L., Arntz, H.-R., Brooks, S. C., Diercks, D., Feitosa-Filho, G. S., Nolan, J. P., Hoek, T. L. V., Walters, D., Wong, A., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.985549 · Cited by 116
New Perspectives on the Role of Autonomic Nervous System in the Genesis of Arrhythmias
Chen, L. S., Zhou, S., Fishbein, M. C., & Chen, P. (2006) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2006.00590.x · Cited by 115
Over- and underestimated parameters in severe Hymenoptera venom–induced anaphylaxis: Cardiovascular medication and absence of urticaria/angioedema
Stoevesandt, J., Hain, J., Kerstan, A., & Trautmann, A. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.03.024 · Cited by 114
Cardioselective beta-blockers for reversible airway disease
Salpeter, S. R., Ormiston, T. M., Salpeter, E. E., & Wood-Baker, R. R. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002992 · Cited by 116
The evolving epidemiology of acute coronary syndromes
Ruff, C. T., & Braunwald, E. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.199 · Cited by 116
Charged Particle Radiation Therapy for Uveal Melanoma: A Systematic Review and Meta-Analysis
Wang, Z., Nabhan, M., Schild, S. E., Stafford, S. L., Petersen, I. A., Foote, R. L., & Murad, M. H. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2012.08.026 · Cited by 113
Association of β-Blocker Therapy With Risks of Adverse Cardiovascular Events and Deaths in Patients With Ischemic Heart Disease Undergoing Noncardiac Surgery
Andersson, C., Mérie, C., Jørgensen, M. E., Gislason, G., Torp-Pedersen, C. T., Overgaard, C., Køber, L., Jensen, P. F., & Hlatky, M. A. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.11349 · Cited by 112
Early intravenous beta-blockers in patients with acute coronary syndrome—A meta-analysis of randomized trials
Chatterjee, S., Chaudhuri, D., Vedanthan, R., Fuster, V., Ibáñez, B., Bangalore, S., & Mukherjee, D. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.10.050 · Cited by 111
“Previous meta-analyses on the role of early beta blockade in ACS did not find significant mortality benefit of early beta-blocker administration in ACS-especially for short-term outcomes [5,6,26].”
BackgroundResult
Norepinephrine transporter function and human cardiovascular disease
Schroeder, C., & Jordan, J. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00492.2012 · Cited by 109
Nuevos datos sobre la prevención secundaria del infarto de miocardio en España. Resultados del estudio PREVESE II
Velasco, J. A., Cosín, J., López-Sendón, J. L., de Teresa, E., de Oya, M., & Sellers, G. (2002) · Revista Española de Cardiología · doi:10.1016/s0300-8932(02)76708-0 · Cited by 108
National evaluation of adherence to β-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance
Kramer, J. M., Hammill, B. G., Anstrom, K. J., Fetterolf, D. E., Snyder, R. L., Charde, J. P., Hoffman, B. S., LaPointe, N. M. A., & Peterson, E. D. (2006) · American Heart Journal · doi:10.1016/j.ahj.2006.02.030 · Cited by 108
Treatment of ischaemic heart disease and stroke in individuals with psychosis under universal healthcare
Kisely, S., Campbell, L. A., & Wang, Y. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.109.067082 · Cited by 116
Cardio‐Selective Beta‐Blocker: Pharmacological Evidence and Their Influence on Exercise Capacity
Ladage, D., Schwinger, R. H. G., & Brixius, K. (2012) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2011.00306.x · Cited by 107
β-Blocker Dialyzability and Mortality in Older Patients Receiving Hemodialysis
Weir, M. A., Dixon, S. N., Fleet, J. L., Roberts, M. A., Hackam, D. G., Oliver, M. J., Suri, R. S., Quinn, R. R., Ozair, S., Beyea, M. M., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014040324 · Cited by 107
An illustrated guide to the methods of meta‐analysis
Sutton, A. J., Abrams, K. R., & Jones, D. R. (2001) · Journal of Evaluation in Clinical Practice · doi:10.1046/j.1365-2753.2001.00281.x · Cited by 106
Predictive value of pharmacological activity for the relative efficacy of antidepressant drugs
Freemantle, N., Anderson, I. M., & Young, P. J. (2000) · The British Journal of Psychiatry · doi:10.1192/bjp.177.4.292 · Cited by 107
Self-citation
Resting Heart Rate is an Independent Predictor of Death in Patients with Colorectal, Pancreatic, and Non-Small Cell Lung Cancer: Results of a Prospective Cardiovascular Long-Term Study
Anker, M. S., Ebner, N., Hildebrandt, B., Springer, J., Sinn, M., Riess, H. B., Anker, S. D., Landmesser, U., Haverkamp, W., & von Haehling, S. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.670 · Cited by 105

Authors: Freemantle, N., Cleland, J., Young, P., Mason, J., & Harrison, J.
Affiliations: University of York (GB)
University of Hull (GB)
Corresponding author: Freemantle, N.
ORCID: Freemantle, N.
Cleland, J.
Mason, J.
Venue: BMJ
Publisher: BMJ
Published: 1999-06-26
Volume: 318
Issue: 7200
Pages: 1730-1737
ISSN: 0007-1447 (ISSN-L)
0959-8138
1468-5833
DOI: 10.1136/bmj.318.7200.1730
PMC: PMC31101
OpenAlex: W2070568974
Cited by: 1,509
References: 34
Citations by year: 2026: 27 · 2025: 43 · 2024: 38 · 2023: 30 · 2022: 42 · 2021: 36 · 2020: 49 · 2019: 47 · 2018: 53 · 2017: 57 · 2016: 58 · 2015: 48 · 2014: 67 · 2013: 74 · 2012: 83
FWCI: 7.55
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: BMJ (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
UCL Discovery (University College London) (submittedVersion)
HighWire Press Open Archive (submittedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Ischemia and Reperfusion
Keywords: beta-blockers, myocardial infarction, secondary prevention, all-cause mortality, reinfarction, cardioselectivity, intrinsic sympathomimetic activity, propranolol, timolol, metoprolol, number needed to treat, predictors of treatment response
MeSH terms: Adrenergic beta-Antagonists, Humans, Myocardial Infarction, Regression Analysis, Randomized Controlled Trials as Topic, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

beta Blockade after myocardial infarction: systematic review and meta regression analysis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks